MedTrace Logo

Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystitis

NCT03844581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-02-19

No results posted yet for this study

Summary

A total of 40 volunteers women with a diagnosis of interstitial cystitis. Their ages ranged from 25 to 40 years old; their body mass index was \> 30 kg/m2 and were randomly assigned to a group (A) received interferential current at the lower abdomen, and also received traditional medicine or group (B) received traditional medicine for 8 successive weeks. Both of the groups received the treatment program for 8 successive weeks. Assessment of pain perception and disability level for all patients in both groups (A\&B) were done through Visual analogue scale, O'Leary-Sant Symptom Index or Interstitial Cystitis Index (ICSI) and blood cortisol concentration were done before and after the treatment program.

Conditions

  • Interstitial Cystitis

Interventions

DEVICE

interferential current

Treatment was applied using four vacuum electrodes with wet sponge, two of them were put under the patient lumber region on a distance from lumber spinous process by five cm on each side and the other two were applied over the suprapubic region parallel to iliac crest.

DRUG

Propiverine Hydrochloride

propiverine hydrochloride 20 mg/once per day in the morning

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • ghada eb elrefaye, professor · Department of Physical Therapy for Women's Health, Faculty of Physical therapy, Cairo University, Egypt.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-01-01
Completion
2019-02-13

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03844581 on ClinicalTrials.gov